HIPK3 and gastric cancer: Regarding drug resistance mechanisms, Qi-Nian Wu et al. [37]revealed that HIPK3 phosphorylates MAP7, regulating its stability and contributing to platinum resistance in gastric cancer through the MEF2C–HIPK3-MAP7 axis.